Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Global Imaging Agents Industry
Date:5/19/2011
ears 2000
through 2006 (includes corresponding Graph/Chart) 154
Table 59: Russian 11-Year Perspective for Imaging Agents by
Product Segment - Percentage Breakdown of Dollar Sales for
Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Markets for Years 2005, 2010 & 2015
(includes corresponding Graph/Chart) 155
18g. REST OF EUROPE 156
Market Analysis 156
Table 60: Rest of Europe Recent Past, Current & Future
Analysis for Imaging Agents by Product Segment - Contrast
Media (X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 156
Table 61: Rest of Europe Historic Review for Imaging Agents
by Product Segment - Contrast Media (X-ray, MRI and
Ultrasound) and Diagnostic Radiopharmaceuticals
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 157
Table 62: Rest of Europe 11-Year Perspective for Imaging
Agents by Product Segment - Percentage Breakdown of Dollar
Sales for Contrast Media (X-ray, MRI and Ultrasound) and
Diagnostic Radiopharmaceuticals Markets for Years 2005, 2010
& 2015 (includes corresponding Graph/Chart) 158
19. ASIA-PACIFIC 159
A.Market Analysis 159
Outlook 159
MRI Market in Asia 159
ANSTO: Leading the Radiopharmaceuticals Market 159
India - A High Potential Market 159
B.Market Analytics 160
Table 63: Asia-Pacific Recent Past, Current & Future
Analysis for Imaging Agents by Product Segment - Contrast
Media (X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2007 thr
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |
Related medicine technology :
1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
3. Directors Forum: PEPFAR and the Global AIDS Response
4. Alfacell Corporation to Present at UBS Global Life Sciences Conference
5. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
6. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
7. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
8. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
9. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
10. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
11. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
Post Your Comments:
(Date:5/18/2013)... YORK , May 18, 2013 ... law firm, is investigating potential securities fraud at ... AVEO). (Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) ... Company and its executives violated federal securities laws ... the Company,s Phase III drug trials for Tivopath ...
(Date:5/17/2013)... -- Medical devices are any medical items that are ... of their different mechanisms, actions and regulatory requirements, medical ... drug trails due to their unique clinical practices. Currently, ... both safety and efficacy (which is left to the ... as the SFDA) evaluate MDs for both safety and ...
(Date:5/17/2013)... 17, 2013 Sorrento Therapeutics, Inc. (OTCBB: SRNE; ... Technology Small Business Technology Transfer Research (STTR) grant ... Infectious Diseases (NIAID), a division of the National ... novel human antibody therapeutics to combat Staphylococcus ... infections, including methicillin-resistant S. aureus (MRSA), ...
Breaking Medicine Technology:Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2Statistical Challenges in Medical Device Trail Evaluation 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4[0] Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm[0] Statistical Challenges in Medical Device Trail Evaluation[0] Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases
... DALLAS , March 22 Texas Instruments Incorporated ... in a family of fully integrated analog front ends (AFEs) ... (EEG) equipment, as well as patient monitoring and consumer medical ... and power consumption by up to 95 percent as compared ...
... , March 22 Galderma Laboratories, L.P. today announced the U.S. Food and Drug Administration (FDA) approval of Differin® (adapalene) Lotion, 0.1%, ... April 2010 . , ... , ... ...
Cached Medicine Technology:Texas Instruments unveils fully integrated analog front end for ECG and EEG applications 2Texas Instruments unveils fully integrated analog front end for ECG and EEG applications 3Texas Instruments unveils fully integrated analog front end for ECG and EEG applications 4Texas Instruments unveils fully integrated analog front end for ECG and EEG applications 5Texas Instruments unveils fully integrated analog front end for ECG and EEG applications 6Texas Instruments unveils fully integrated analog front end for ECG and EEG applications 7Galderma Received FDA Approval of Differin(R) (adapalene) Lotion, 0.1%, the First Retinoid Available in Lotion Formulation 2Galderma Received FDA Approval of Differin(R) (adapalene) Lotion, 0.1%, the First Retinoid Available in Lotion Formulation 3Galderma Received FDA Approval of Differin(R) (adapalene) Lotion, 0.1%, the First Retinoid Available in Lotion Formulation 4Galderma Received FDA Approval of Differin(R) (adapalene) Lotion, 0.1%, the First Retinoid Available in Lotion Formulation 5Galderma Received FDA Approval of Differin(R) (adapalene) Lotion, 0.1%, the First Retinoid Available in Lotion Formulation 6Galderma Received FDA Approval of Differin(R) (adapalene) Lotion, 0.1%, the First Retinoid Available in Lotion Formulation 7(Date:5/19/2013)... People in Minnesota have a great option ... offering its 28 Day Fat Loss Formula. The best ... of their own home. The product sells for $135 dollars ... be accessed here: http://altmanfitness.com/28-day-fat-loss-formula/ , “Bikini season is ... now, but after using the 28 Day Fat Loss Formula ...
(Date:5/19/2013)... New York, New York (PRWEB) May 19, 2013 ... move forward in a federal litigation now underway in ... to a Case Management Order dated May 3rd, the ... the Bellwether Nominee Pool to eight cases rather than ... litigation is scheduled for Thursday, May 23rd. (In re: ...
(Date:5/19/2013)... Park City, Utah (PRWEB) May 19, 2013 ... new information on small business health insurance ... alternatives to traditional employer sponsored health benefits, is ... contribution and health reimbursement arrangements . ... businesses, start-ups, and the self-employed intrinsically know the ...
(Date:5/19/2013)... According to a new market research ... – 2018): By Applications (Healthcare (Endoscopy, Radiology, Ophthalmology), ... Contact IS, Infrared, X-Ray) And Geography" published by ... $8.00 billion in 2012 and is expected to ... CAGR of 3.84% from 2013 to 2018. In ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 These ... for US, UK, Spain, Japan, Italy, Germany and ... the molecular diagnostics laboratory practice, as well as ... with significant market impact during the next five ... probe and biochip technologies, test formats, detection methodologies, ...
Breaking Medicine News(10 mins):Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 3Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 2Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 3Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 2Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 4[0] 28 Day Fat Loss Formula Offered To Minnesota Residents[0] Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation[0] Zane Benefits Publishes New Information on Small Business Health Insurance[0] Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets[0] Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com
... Drizzled with Pink White-Chocolate, CHICAGO, Oct. 8 ... announce its new Pink Ribbon Pretzel available throughout,October, ... resources and emotional support to those touched by,breast ... of,the breast cancer awareness ribbon, and topped with ...
... in the elderly increases the risk of subsequent mental ... intellectual decline, University of Rochester Medical Center psychiatrists and ... or prevention of depression would reduce or prevent cognitive ... that would be our hope, said Jeffrey M. Lyness, ...
... risk, experts say , , MONDAY, Oct. 8 (HealthDay News) -- ... fertilizer, according to a new study that finds human urine ... , The "yuck" factor aside, scientists who used urine to ... may not be a bad idea. , "Urine is a ...
... YORK, Oct. 8 Forest Laboratories, Inc.,(NYSE: ... pharmaceutical,products, will release its Fiscal 2008 Second Quarter ... Tuesday, October 16, 2007. Later that,day, at 10:00 ... where Dr. Lawrence,Olanoff, President and Chief Operating Officer ...
... busy fall season in,full swing, Hands2GO(R), the nation,s first ... against this year,s winter,cold and flu season. Typically, the ... "Regular hand washing, combined with Hands2GO hand sanitizers and ... year," said Francine,Glick, CEO and founder of Hands2GO. "It,s ...
... on the Internet: Thursday, October 11, 2007, 9 AM-4:00 PM, ... on employer-sponsored wellness programs that will work ... new economic model to address overweight and ... well as employers, e.g. Mayo Clinic, Hannaford ...
Cached Medicine News:Health News:Kim & Scott's Gourmet Pretzels(TM) Supports Breast Cancer Organizations With Its New Pink Ribbon Pretzel 2Health News:Depression can foreshadow intellectual decline in older people 2Health News:Human Urine Safe, Productive Fertilizer 2Health News:Human Urine Safe, Productive Fertilizer 3Health News:Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Second Quarter Earnings 2Health News:Hands2GO(R) Hand Sanitizer Offers Alcohol-Free Alternative to Stopping the Spread of Flu at School and Work 2Health News:Hands2GO(R) Hand Sanitizer Offers Alcohol-Free Alternative to Stopping the Spread of Flu at School and Work 3Health News:Webcast Alert: Expert Group Urges Businesses to Get Real About Weight Loss 2Kim & Scott's Gourmet Pretzels(TM) Supports Breast Cancer Organizations With Its New Pink Ribbon PretzelDepression can foreshadow intellectual decline in older peopleHuman Urine Safe, Productive FertilizerForest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Second Quarter EarningsHands2GO(R) Hand Sanitizer Offers Alcohol-Free Alternative to Stopping the Spread of Flu at School and WorkWebcast Alert: Expert Group Urges Businesses to Get Real About Weight Loss
... The instrument includes the ... has increased illumination for ... illumination. The Copeland retinoscope ... handle, and extended battery ...
... stereopsis from 800 to 40 ... young as 2 years of ... from left to right., ,Randot ... Book #1: 200 & 100 ...
... EasyEye is the only handheld non-contact tonometer with ... is streamlined, quiet and now, with constant ... a gentle puff of air. You can prove ... on the patient's hand before you start. ...
... 2000 Phenytoin Assay is a ... use in the quantitative analysis ... or plasma. Kits are packaged ... Roche COBAS MIRA, COBAS MIRA ...
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |